Name:
DTPA CaNa3-SN Radiofarma® TC

Active Principle:
Trisodium Monocalcium Diethylenediamine Pentaacetate

Therapeutic Action:
According to the route of administration, it is indicated for:

1) Intravenous Administration:
1.1. Renograms for the evaluation of renal perfusion and function.
1.2. Gammagraphy for the study of the urinary tract.
1.3. Estimation of the glomerular filtration rate.
1.4. Cerebral angiography and gammagraphy.

2) Inhalation Administration:
2.1. Pulmonary ventilation scintigraphy and evaluation of embolism in adult or pediatric patients.

3) Oral Administration:
3.1. Esophageal reflux scintigraphy.
3.2. Gastric emptying scintigraphy.